PAPER Schüpbach M, Gargiulo M, Welter ML, Mallet L, Béhar C, Houeto JL, Maltête D, Mesnage V, Agid Y
SEARCH RESULTS
331209 RESULTS
PAPER Walker HC, Phillips DE, Boswell DB, Guthrie BL, Guthrie SL, Nicholas AP, Montgomery EB, Watts RL
Relief of acquired stuttering associated with Parkinson's disease by unilateral left subthalamic brain stimulation.
J Speech Lang Hear Res. 2009 Dec;52(6):1652-7. PubMed: 19951930PAPER Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J
Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):315-9. PubMed: 19726415PAPER Péron J, Biseul I, Leray E, Vicente S, Le Jeune F, Drapier S, Drapier D, Sauleau P, Haegelen C, Vérin M
Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease.
Neuropsychology. 2010 Jan;24(1):1-8. PubMed: 20063943PAPER Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schüpbach M, D'Ambrosia J, Thobois S, Tamma F, Herzog J, Speelman JD, Samanta J, Kubu C, Rossignol H, Poon YY, Saint-Cyr JA, Ardouin C, Moro E
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.
Brain. 2008 Oct;131(Pt 10):2720-8. PubMed: 18941146PAPER Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.
J Neurol Neurosurg Psychiatry. 2007 May;78(5):517-9. PubMed: 17210626David Corbin on Geneva: At Springfield Meeting, Soul-Searching About Dearth of Drugs
COMMENT Reply to Comment by Craig Atwood and Kentaro Hayashi Many thanks to Atwood and Hayashi for their excellent comment on estrogen-based therapy for Alzheimer's. Although they contend that big pharma has not shown the level interest that this deserves, i
Kathleen Gates
Senior connectionsSuperior, United States
RFP
ANTIBODY polyclonal manufacturer Cat# ab34764 immunogen = full length RFP fusion protein from mushroom polyp coral Discosoma liquid, BSA, saline, phosphate, azide, affinity purified, FITC conj. reacts with RFP tagged proteins; no reaction was observed against seru
RFP
ANTIBODY polyclonal manufacturer Cat# ab62341 immunogen = recombinant RFP expressed in E. coli liquid, BSA, PBS, glycerol, Thimerosal, affinity purified reacts with RFP IgG Tools Abcam Rabbit Non-specific RFP http://alzforum.org/res/com/ant/default.asp?antibodyID=
Deep-Brain Stimulation: Steadies the Body, But What About the Mind?
RESEARCH NEWS 2010-05-24 Research News With a few electrodes deftly threaded into a troubled brain, surgeons can often still the embarrassing tremors and alleviate the painful muscle cramps that come with Parkinson disease. But this deep-brain stimulation does not treat all that
ApoE receptor 2
ANTIBODY polyclonal manufacturer cat# LS-C69191 Immunogen = synthetic peptide made to a C-terminal portion of the human ApoER2 protein sequence (between residues 863-963) liquid, tris-glycine saline, azide, affinity purified Apolipoprotein E receptor 2 IgG Apolipo
ApoE receptor 2
ANTIBODY polyclonal manufacturer cat# LS-C69192 Immunogen = synthetic peptide made to a C-terminal portion of the human ApoER2 protein sequence (between residues 800-900) liquid, tris-glycine saline, azide, affinity purified Apolipoprotein E receptor 2 IgG Apolipo
ApoE receptor 2
ANTIBODY polyclonal manufacturer cat# LS-C54522 Immunogen = synthetic peptide (C-R N W K R K N T K S M N F D) from an internal region of human ApoE receptor 2 lyophilized, TBS, BSA, azide, affinity purified Apolipoprotein E receptor 2 IgG Apolipoproteins LifeSpan
ApoE receptor 2
ANTIBODY polyclonal manufacturer cat# LS-C102134 Immunogen = synthetic peptide corresp. to human ApoE receptor 2 lyophilized, PBS, sucrose, azide, affinity purified Apolipoprotein E receptor 2 IgG Apolipoproteins LifeSpan Biosciences, Inc. Rabbit Human Mouse Rat A
Current Filters
No filters selected